0001104659-12-060038.txt : 20121101 0001104659-12-060038.hdr.sgml : 20121101 20120824153719 ACCESSION NUMBER: 0001104659-12-060038 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 CORRESP 1 filename1.htm

 

[AMAG Pharmaceuticals, Inc. letterhead]

 

VIA EDGAR

 

August 24, 2012

 

Mr. Jim B. Rosenberg

Senior Assistant Chief Accountant, Division of Corporation Finance

U.S. Securities and Exchange Commission

Mail Stop 4561

100 F St., N.E.

Washington, D.C. 20549

 

Re:                             AMAG Pharmaceuticals, Inc. (File No.: 001-10865)

SEC Comment Letter dated August 17, 2012

 

Dear Mr. Rosenberg:

 

On behalf of AMAG Pharmaceuticals, Inc. (“AMAG”), we refer to the SEC comment letter dated August 17, 2012 sent to AMAG (the “Letter”).  As discussed with Mr. Mark Brunhofer, Staff Accountant, we will be responding to the Letter on or prior to September 14, 2012.  The additional time is required in order to properly review and finalize the responses.

 

If you require additional information, please telephone the undersigned at (617) 498-3376.

 

Sincerely,

 

/s/ Scott A. Holmes

 

Scott A. Holmes

 

Chief Accounting Officer, Vice President and Controller

 

 

 

cc:                                Miguel J. Vega, Esq.

Cooley LLP